0.4749
price up icon3.24%   0.0149
pre-market  Vorhandelsmarkt:  .48   0.0051   +1.07%
loading
Schlusskurs vom Vortag:
$0.46
Offen:
$0.46
24-Stunden-Volumen:
898.35K
Relative Volume:
0.39
Marktkapitalisierung:
$67.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.3518
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
+12.35%
1M Leistung:
+38.50%
6M Leistung:
-24.43%
1J Leistung:
-90.67%
1-Tages-Spanne:
Value
$0.4438
$0.478
1-Wochen-Bereich:
Value
$0.407
$0.485
52-Wochen-Spanne:
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
Firmenname
Applied Therapeutics Inc
Name
Telefon
212-220-9226
Name
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
Mitarbeiter
36
Name
Twitter
@Applied_Tx
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
APLT's Discussions on Twitter

Vergleichen Sie APLT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
APLT
Applied Therapeutics Inc
0.4749 59.84M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-23 Herabstufung William Blair Outperform → Mkt Perform
2024-12-02 Herabstufung UBS Buy → Neutral
2024-11-29 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-07-31 Eingeleitet William Blair Outperform
2024-03-26 Eingeleitet RBC Capital Mkts Outperform
2024-02-22 Eingeleitet Leerink Partners Outperform
2022-01-04 Herabstufung Barclays Overweight → Equal Weight
2021-08-27 Herabstufung Goldman Neutral → Sell
2021-06-25 Fortgesetzt Goldman Neutral
2020-10-08 Eingeleitet Truist Buy
2020-04-22 Eingeleitet Goldman Buy
2020-02-27 Eingeleitet Barclays Overweight
2019-06-10 Eingeleitet Citigroup Buy
2019-06-10 Eingeleitet Cowen Outperform
2019-06-10 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten

pulisher
Jul 22, 2025

How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Applied Therapeutics Inc. Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Applied Therapeutics Inc. stock priceConsistently superior profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

Is Applied Therapeutics Inc. a good long term investmentExplosive earnings growth - printweek.in

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Applied Therapeutics Inc. stockExplosive trading opportunities - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 15, 2025

What makes Applied Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Applied Therapeutics Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Applied Therapeutics Inc. stock attracts strong analyst attentionFree Investing Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Why Did Rapport Therapeutics Plunge 15.68%? Regulatory Setbacks, Financial Strain - AInvest

Jul 14, 2025
pulisher
Jul 08, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire

Jul 08, 2025
pulisher
Jul 06, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit – APLT - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 03, 2025

Applied Therapeutics Requests to Dismiss Class Action Filed by Investors - TradingView

Jul 03, 2025
pulisher
Jul 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire

Jul 03, 2025
pulisher
Jun 29, 2025

Applied Therapeutics Plummets 15% Amid Technical Mystery: What's Behind the Drop? - AInvest

Jun 29, 2025
pulisher
Jun 23, 2025

Applied Therapeutics Plummets 12.5%: What’s Behind the Unexplained Sell-Off? - AInvest

Jun 23, 2025
pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces New Chief Medical Officer - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

APLT Announces Key Executive Promotions | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments - GlobeNewswire

Jun 17, 2025
pulisher
Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Purchases 64,316 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics Elects New Director at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Buys New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat

Jun 10, 2025
pulisher
Jun 09, 2025

Wellington Management Group LLP Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Acquired by Millennium Management LLC - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Applied Therapeutics, Inc. (APLT) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 06, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 05, 2025

Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):